ascopubs.org

Exploring the role of the combination of FDG PET plus whole body MRI for staging newly diagnosed and relapsed/refractory multiple myeloma: A prospective trial.

OriCAR-017, a novel GPRC5D-targeting CAR-T, in patients with relapsed/refractory multiple myeloma: Long term follow-up results of phase 1 study (POLARIS). This is an ASCO Meeting Abstract from the ...
ascopubs.org

Exploring the role of the combination of FDG-PET plus whole body MRI for staging patients with high-risk smoldering myeloma: A prospective trial.

Unveiling consistency: A large-scale analysis of conference proceedings and subsequent publications in oncology clinical trials using large language models. This is an ASCO Meeting Abstract from the ...
BioWorld

[18F]CNL-02, a PET radioligand for imaging MC-I in the brain

Researchers from Massachusetts General Hospital and affiliated organizations have published preclinical data for [18F]CNL-02, a positron emission tomography (PET) radioligand targeting mitochondrial ...